• Janhavi Narendra Jawade
• Vikas Gawande
• Dr. Shivshankar Mhaske

Withania coagulans, a medicinal plant belonging to the Solanaceae family, has been traditionally used in Ayurvedic medicine for various therapeutic purposes, particularly in the treatment of metabolic disorders such as diabetes. This study aims to explore the antidiabetic potential of Withania coagulans, focusing on its bioactive compounds, mechanisms of action, and therapeutic efficacy in managing hyperglycemia. The plant has shown promise in regulating blood glucose levels, improving insulin sensitivity, and mitigating oxidative stress, which are key factors in the pathophysiology of diabetes. The study reviews the phytochemical composition of Withania coagulans, highlighting its alkaloids, saponins, and flavonoids, which contribute to its antidiabetic properties. Preclinical and clinical studies suggest that Withania coagulans possesses anti-hyperglycemic, antioxidant, and anti-inflammatory effects, making it a promising natural adjunct in diabetes management. This research aims to provide a comprehensive understanding of Withania coagulans as a potential therapeutic agent in diabetes treatment, contributing to the growing interest in plant-based remedies for chronic diseases.

Withania Coagulans, antidiabetic property, traditional medicine, herbal medicine

"Study of Withania Coagulans having Antidiabetic activity used in the treatment of Diabetes ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 12, page no.g521-g530, December-2024, Available :http://www.jetir.org/papers/JETIR2412660.pdf

"Study of Withania Coagulans having Antidiabetic activity used in the treatment of Diabetes ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 12, page no. ppg521-g530, December-2024, Available at : http://www.jetir.org/papers/JETIR2412660.pdf